Health authorities in England have launched a vaccination campaign targeting young people following concerns about meningitis B transmission. The initiative offers free MenB vaccines to eligible individuals, with particular focus on those entering higher education or residential college settings for the first time.
The campaign emerged after an outbreak in Kent, which was characterized as unprecedented and explosive, resulting in 29 confirmed or suspected cases and two deaths within weeks. Approximately 90,000 doses have already been distributed, with an additional 135,000 scheduled for administration in subsequent weeks.
Eligible recipients include individuals aged 17 and 18 in sixth form, as well as students under 25 entering university or residential further education for the first time this autumn. Those born between September 1, 2007 and August 31, 2008 are included, along with international students and those from other UK nations studying in England. A total of approximately one million young people are expected to be eligible across England.
The vaccine is administered in two doses, spaced at least 28 days apart, with both required for maximum protection. Bookings can be made through high street pharmacies, and the NHS National Booking Service is available for eligible 17 and 18-year-olds already registered with a general practitioner. Walk-in services are also available at participating pharmacies for those born on or after July 21, 2001.
Meningitis B can cause serious complications including inflammation of the brain lining and sepsis, potentially resulting in life-changing disabilities or fatality. Research indicates first-year university students face approximately seven times higher risk compared to similar-aged peers not attending university, partly due to increased social mixing and shared accommodation. The MenB vaccine was introduced to the childhood immunization program for babies born after July 1, 2015, but older teenagers and young adults had not previously received routine vaccination. Common side effects include localized swelling and mild systemic symptoms, typically resolving within one to two days.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI